AI in Biotechnology Market to Hit $26.94 Bn Driven By AI-Powered Drug Discovery & Precision Medicine

NEW YORK - Aug. 7, 2026 - PRLog -- The AI in Biotechnology Market is witnessing exponential growth as biotechnology companies, pharmaceutical firms, and research organizations increasingly integrate artificial intelligence, machine learning, and advanced analytics into biological research and healthcare innovation. According to the latest study by Acumen Research and Consulting, the global AI in Biotechnology Market was valued at USD 4.13 Billion in 2025 and is projected to surpass USD 26.94 Billion by 2035, expanding at a CAGR of 20.6% from 2026 to 2035.

AI in Biotechnology Market Highlights

• The global market size reached USD 4.13 Billion in 2025.
• The market is expected to exceed USD 26.94 Billion by 2035.
• North America dominated the market with a 41% revenue share in 2025.
• Asia Pacific is expected to register the fastest growth during the forecast period.
• The software segment accounted for 49.4% market share in 2025.
• The drug discovery and development segment led applications with a 35% share in 2025.

Download report preview: https://www.acumenresearchandconsulting.com/request-sample/3925

Explore more insights: https://www.acumenresearchandconsulting.com/ai-in-biotechnology-market

AI-Driven Drug Discovery Accelerates Market Expansion

AI in Biotechnology Market is gaining significant momentum as artificial intelligence technologies help researchers analyze complex biological datasets, identify drug targets, predict molecular interactions, and accelerate therapeutic development.

Precision Medicine and Clinical Trial Optimization Create New Opportunities

Growing adoption of personalized medicine is a major factor supporting the expansion of the AI in Biotechnology Market. AI algorithms can analyze genomic information, biological datasets, and patient records to support personalized treatment strategies and improve healthcare outcomes.

Segment Insights Highlight Rising Demand for AI Solutions

By component, the software segment dominated the market in 2025 with a 49.4% share, driven by increasing demand for AI platforms, predictive analytics tools, bioinformatics solutions, and cloud-based technologies that support large-scale biological data processing.

Among end users, pharmaceutical companies led the market with a 36% revenue share in 2025, as major pharmaceutical organizations continue investing in AI-enabled research and development platforms to improve drug development efficiency.

AI in Biotechnology Market Regional Outlook

North America dominated the AI in Biotechnology Market in 2025, accounting for 41% of global revenue, supported by a strong biotechnology ecosystem, advanced healthcare infrastructure, significant AI investments, and the presence of leading pharmaceutical and technology companies.

Asia Pacific is expected to witness the fastest growth during the forecast period, driven by increasing government initiatives, expanding biotechnology research capabilities, rising healthcare investments, and growing adoption of AI-based solutions across emerging economies.